HCPCS code lookup
HCPCS Level II
C9093
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
Ask Rivvi
- Code
- C9093
- Description
- Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
HCPCS Level II
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
Free to start. Most teams are using it the same day.